Skip to content

Gut Microbiota and Antibiotics - Prevention of Side Effects by New Prebiotics

Gut Microbiota and Antibiotics - Prevention of Side Effects by New Prebiotics

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03523936
Enrollment
30
Registered
2018-05-14
Start date
2018-06-01
Completion date
2019-12-31
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Changes in the Gut Microbiota During an Antibiotic Treatment

Keywords

antibiotics, prebiotics, dysbiosis

Brief summary

Antibiotics disturb the balance of gut microbiota causing dysbiosis. The purpose of this double-blind placebo controlled intervention study is to investigate whether a new prebiotic product could prevent the side effects of antibiotics.

Detailed description

Thirty children (2-6 years of age), who require antibiotic treatment assessed by a doctor, will be enrolled in the study. The children will be randomized to receive either the prebiotic product or placebo during the course of antibiotic treatment. The children will give a faecal sample in the beginning and at the end of the study. The samples will be used for the analysis of microbiota and differences in the microbiota between the groups.

Interventions

DIETARY_SUPPLEMENTPrebiotic product

Prebiotic product used during the course of antibiotic treatment

DIETARY_SUPPLEMENTPlacebo

Placebo

Sponsors

VTT Technical Research Centre of Finland
CollaboratorOTHER
Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Intervention model description

Double blind placebo controlled trial

Eligibility

Sex/Gender
ALL
Age
2 Years to 6 Years
Healthy volunteers
No

Inclusion criteria

* An infection requiring antibiotic treatment assessed by a doctor

Exclusion criteria

* Coaeliac disease or allergy to cereals, use of other prebiotic/probiotic product during the study

Design outcomes

Primary

MeasureTime frameDescription
Changes of gut microbiota during antibiotic treatmentOne weekGut microbiota and antibiotics - Prevention of side effects by new prebiotics

Contacts

Primary ContactSeppo salminen, PhD
sepsal@utu.fi+35823336880
Backup ContactErika Isolaur, MD,PhD
eriiso@utu.fi+35823130000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026